GRADE Guidelines: 2. Framing the question and deciding on important outcomes;GRADE-Leitlinien: 2. Formulierung der Fragestellung und Entscheidung über wichtige Endpunkte

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen

Volumn 106, Issue 5, 2012, Pages 369-376

  Langer, Gero ^a   Meerpohl, Joerg J ^b,c   Perleth, Matthias ^d   Gartlehner, Gerald ^e   Kaminski Hartenthaler, Angela ^e   Schünemann, Holger ^f  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Abteilung für Medizinische Biometrie und Statistik   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d Abteilung Fachberatung Medizin   (Germany)

^e DANUBE UNIVERSITY KREMS   (Austria)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

GRADE; guideline development; indirectness; patient important outcomes; PICO; quality of evidence; surrogate

Indexed keywords

EID: 84864279183     PISSN: 18659217     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.zefq.2012.05.018     Document Type: Article

References (16)

1. H.J. Schunemann, D. Cook, and G. Guyatt Methodology for antithrombotic and thrombolytic therapy guideline development: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl 2008 113S 122S (Pubitemid 351892963)
2. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
3. L.M. Letelier, K. Udol, J. Ena, B. Weaver, and G.H. Guyatt Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis Arch Intern Med 163 2003 777 785 (Pubitemid 36438049)
4. G. Guyatt, A.D. Oxman, R. Kunz, J. Woodcock, J. Brozek, and M. Helfand Grade Guidelines: 7. Rating the quality of evidence: Inconsistency J Clin Epidemiol 64 2011 1294 1302
5. J. Eikelboom, G. Guyatt, and J. Hirsh Guidelines for anticoagulant use in acute coronary syndromes Lancet 371 2008 1559 1561 (Pubitemid 351635926)
6. T.A. Furukawa, G.H. Guyatt, and L.E. Griffith Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses Int J Epidemiol 31 2002 72 76 (Pubitemid 34284903)
7. C.H. Schmid, J. Lau, M.W. McIntosh, and J.C. Cappelleri An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials Stat Med 17 1998 1923 1942 (Pubitemid 28425258)
8. J.J. Deeks Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes Stat Med 21 2002 1575 1600 (Pubitemid 34746064)
9. D.E. Singer, G.W. Albers, J.E. Dalen, M.C. Fang, A.S. Go, and J.L. Halperin Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl 2008 546S 592S (Pubitemid 351892972)
10. H.C. Bucher, L.E. Griffith, and G.H. Guyatt Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials Ann Intern Med 128 1998 89 95 (Pubitemid 28053129)
11. H.A. Bischoff-Ferrari, W.C. Willett, J.B. Wong, E. Giovannucci, T. Dietrich, and B. Dawson-Hughes Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials JAMA 293 2005 2257 2264 (Pubitemid 40629192)
12. V.M. Montori, G.Y. Gandhi, and G.H. Guyatt Patient-important outcomes in diabetes - time for consensus Lancet 370 2007 1104 1106 (Pubitemid 47464565)
13. G.Y. Gandhi, M.H. Murad, A. Fujiyoshi, R.J. Mullan, D.N. Flynn, and M.B. Elamin Patient-important outcomes in registered diabetes trials JAMA 299 2008 2543 2549 (Pubitemid 351787210)
14. H. Bucher, R. Kunz, D. Cook, A. Holbrook, and G. Guyatt Surrogate outcomes G. Guyatt, D. Rennie, M. Meade, D. Cook, The Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice 2nd ed. 2008 McGraw-Hill New York, New York
15. K.E. Lasser, P.D. Allen, S.J. Woolhandler, D.U. Himmelstein, S.M. Wolfe, and D.H. Bor Timing of new black box warnings and withdrawals for prescription medications JAMA 287 2002 2215 2220 (Pubitemid 34441937)
16. S.L. Bowker, S.R. Majumdar, P. Veugelers, and J.A. Johnson Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 2006 254 258 (Pubitemid 44106500)